Company Filing History:
Years Active: 2006
Title: Innovations of Peter Cullis in Pharmaceutical Technology
Introduction
Peter Cullis is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of novel drug delivery systems. His work focuses on enhancing the efficacy of therapeutic compounds through innovative methods.
Latest Patents
Peter Cullis holds a patent for "Polyanionic polymers which enhance fusogenicity." This invention relates to the amphiphilic polyelectrolyte, poly(2-ethylacrylic acid), and covalently bonded lipids to generate Lipo-PEAA. These Lipo-PEAA are utilized to create pH-sensitive liposomes that become unstable, permeable, or fusogenic with specific pH changes. The invention also describes methods for delivering therapeutic compounds and drugs to target cells by administering these pH-sensitive liposomes to a host.
Career Highlights
Peter Cullis is associated with Inex Pharmaceuticals Corporation, where he has played a vital role in advancing pharmaceutical innovations. His work has been instrumental in developing new strategies for drug delivery, which have the potential to improve patient outcomes significantly.
Collaborations
Peter has collaborated with notable colleagues, including Tao Chen and Yuehua He, to further enhance the impact of his research and innovations in the pharmaceutical field.
Conclusion
Peter Cullis is a key figure in the realm of pharmaceutical technology, with a focus on innovative drug delivery systems. His contributions, particularly through his patent on pH-sensitive liposomes, showcase his commitment to advancing medical science and improving therapeutic efficacy.